Improving the Use of FDA Advisory Committees.

Daval, C Joseph Ross; Kesselheim, Aaron S; Sarpatwari, Ameet

Daval, C Joseph Ross; Kesselheim, Aaron S; Sarpatwari, Ameet.

Daval CJR; From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
Kesselheim AS; From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.
Sarpatwari A; From the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.

N Engl J Med ; 387(8): 675-677, 2022 08 25.

Artículo en Inglés | MEDLINE | ID: covidwho-2016973

Asunto(s)

Comités Consultivos; Aprobación de Drogas; Humanos; Estados Unidos; United States Food and Drug Administration

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Aprobación de Drogas / Comités Consultivos Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: N Engl J Med Año: 2022 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google